Survival after cystectomy for invasive bladder cancer

European Journal of Surgical Oncology

Volumn 36, Issue 3, 2010, Pages 292-297

  de Vries, R R ^a   Nieuwenhuijzen, J A ^a   Vincent, A ^a   van Tinteren, H ^a   Horenblas, S ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Bladder neoplasms; Cystectomy; High risk non muscle invasive bladder cancer; Survival; Transitional cell carcinoma

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NETHERLANDS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 76449087325     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.11.012     Document Type: Article

References (16)

1. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 3 (2006) 466-477
2. Oosterlinck W, van der Meijden AP, Sylvester R, et al. Guidelines on TaT1(non-muscle invasive) Bladder cancer. 1-3-2006 [Ref Type: Generic].
3. Nieuwenhuijzen J.A., Pos F., Moonen L.M., Hart A.A., and Horenblas S. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol 48 2 (2005) 239-245
4. Wittekind Ch., Greene F.L., Henson D.E., Hutter R.V.P., and Sobin L.H. TNM classification of malignant tumours (2002), Wiley-Liss
5. Schrier B.P., Hollander M.P., van Rhijn B.W., Kiemeney L.A., and Witjes J.A. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 3 (2004) 292-296
6. Yiou R., Patard J.J., Benhard H., Abbou C.C., and Chopin D.K. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 89 4 (2002) 374-378
7. Lee C.T., Dunn R.L., Ingold C., Montie J.E., and Wood Jr. D.P. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion. Urology 69 6 (2007) 1068-1072
8. Ficarra V., Dalpiaz O., Alrabi N., Novara G., Galfano A., and Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95 6 (2005) 786-790
9. Ghoneim M.A., bdel-Latif M., el-Mekresh M., et al. Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol 180 1 (2008) 121-127
10. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19 3 (2001) 666-675
11. Herr H.W., and Sogani P.C. Does early cystectomy improve the survival of patients with high risk superficial bladder tumours?. J Urol 166 4 (2001) 1296-1299
12. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., and Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164 3 Pt 1 (2000) 680-684
13. Wiesner C., Pfitzenmaier J., Faldum A., Gillitzer R., Melchior S.W., and Thuroff J.W. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95 3 (2005) 301-305
14. Mungan N.A., Kiemeney L.A., van Dijck J.A., van der Poel H.G., and Witjes J.A. Gender differences in stage distribution of bladder cancer. Urology 55 3 (2000) 368-371
15. Herr H.W., Donat S.M., and Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. J Urol 177 1 (2007) 75-79
16. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Bohle A., and Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54 2 (2008) 303-314